• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过转染酿酒酵母的线粒体内对鱼藤酮不敏感的NADH-醌氧化还原酶(NDI1)基因来调节人肾293细胞的氧化磷酸化作用。

Modulation of oxidative phosphorylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae.

作者信息

Seo B B, Matsuno-Yagi A, Yagi T

机构信息

Division of Biochemistry, Department of Experimental and Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Biochim Biophys Acta. 1999 May 26;1412(1):56-65. doi: 10.1016/s0005-2728(99)00051-1.

DOI:10.1016/s0005-2728(99)00051-1
PMID:10354494
Abstract

In contrast to the mitochondrial proton-translocating NADH-quinone oxidoreductase (complex I), which consists of at least 43 different subunits, the internal rotenone-insensitive NADH-quinone oxidoreductase (Ndi1) of Saccharomyces cerevisiae is a single polypeptide enzyme. The NDI1 gene was stably transfected into the human embryonal kidney 293 (HEK 293) cells. The transfected NDI1 gene was then transcribed and translated in the HEK 293 cells to produce the functional enzyme. The immunochemical and immunofluorescence analyses indicated that the expressed Ndi1 polypeptide was located to the inner mitochondrial membranes. The expression of Ndi1 did not alter the content of existing complex I in the HEK 293 mitochondria, suggesting that the expressed Ndi1 enzyme does not displace the endogenous complex I. The NADH oxidase activity of the NDI1-transfected HEK 293 cells was not affected by rotenone but was inhibited by flavone. The ADP/O ratios coupled to NADH oxidation were lowered from 2.4 to 1.8 by NDI1-transfection while the ADP/O ratios coupled to succinate oxidation (1.6) were not changed. The NDI1-transfected HEK 293 cells were able to grow in media containing a complex I inhibitor such as rotenone and 1-methyl-4-phenylpyridinium ion. The potential usefulness of incorporating the Ndi1 protein into mitochondria of human cells is discussed.

摘要

与由至少43个不同亚基组成的线粒体质子转运NADH-醌氧化还原酶(复合体I)不同,酿酒酵母的内源性鱼藤酮不敏感NADH-醌氧化还原酶(Ndi1)是一种单多肽酶。NDI1基因被稳定转染到人胚肾293(HEK 293)细胞中。然后,转染的NDI1基因在HEK 293细胞中进行转录和翻译,以产生功能性酶。免疫化学和免疫荧光分析表明,表达的Ndi1多肽定位于线粒体内膜。Ndi1的表达并未改变HEK 293线粒体中现有复合体I的含量,这表明表达的Ndi1酶不会取代内源性复合体I。转染NDI1的HEK 293细胞的NADH氧化酶活性不受鱼藤酮影响,但受黄酮抑制。与NADH氧化偶联的ADP/O比值因NDI1转染而从2.4降至1.8,而与琥珀酸氧化偶联的ADP/O比值(1.6)未发生变化。转染NDI1的HEK 293细胞能够在含有复合体I抑制剂如鱼藤酮和1-甲基-4-苯基吡啶离子的培养基中生长。文中讨论了将Ndi1蛋白整合到人类细胞线粒体中的潜在用途。

相似文献

1
Modulation of oxidative phosphorylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae.通过转染酿酒酵母的线粒体内对鱼藤酮不敏感的NADH-醌氧化还原酶(NDI1)基因来调节人肾293细胞的氧化磷酸化作用。
Biochim Biophys Acta. 1999 May 26;1412(1):56-65. doi: 10.1016/s0005-2728(99)00051-1.
2
Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells.复合体I缺陷的分子疗法:酿酒酵母线粒体对鱼藤酮不敏感的内源性NADH-醌氧化还原酶可恢复复合体I缺陷的哺乳动物细胞的NADH氧化酶活性。
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9167-71. doi: 10.1073/pnas.95.16.9167.
3
Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria: the enzyme expressed in Escherichia coli acts as a member of the respiratory chain in the host cells.酿酒酵母线粒体对鱼藤酮不敏感的内源性NADH-醌氧化还原酶:在大肠杆菌中表达的该酶在宿主细胞中作为呼吸链的一员发挥作用。
FEBS Lett. 1998 Jan 2;421(1):37-40. doi: 10.1016/s0014-5793(97)01533-0.
4
Lack of complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene.携带线粒体DNA编码的ND4亚基突变的人类细胞中缺乏复合体I活性,可通过酿酒酵母烟酰胺腺嘌呤二核苷酸-醌氧化还原酶(NDI1)基因来纠正。
J Biol Chem. 2001 Oct 19;276(42):38808-13. doi: 10.1074/jbc.M106363200. Epub 2001 Jul 30.
5
Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells.利用酿酒酵母的NADH-醌氧化还原酶(NDI1)基因作为治疗人类细胞中复合物I缺陷的一种可能方法。
J Biol Chem. 2000 Dec 1;275(48):37774-8. doi: 10.1074/jbc.M007033200.
6
Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo.酵母 NDI1 的基因治疗对鱼藤酮诱导的帕金森病模型中线粒体复合体 I 功能障碍的体内外研究。
Mol Med. 2022 Mar 7;28(1):29. doi: 10.1186/s10020-022-00456-x.
7
Xenotransplantation of mitochondrial electron transfer enzyme, Ndi1, in myocardial reperfusion injury.线粒体电子传递酶 Ndi1 的异种移植在心肌再灌注损伤中的作用。
PLoS One. 2011 Feb 14;6(2):e16288. doi: 10.1371/journal.pone.0016288.
8
Can a single subunit yeast NADH dehydrogenase (Ndi1) remedy diseases caused by respiratory complex I defects?单一亚基的酵母NADH脱氢酶(Ndi1)能否治疗由呼吸链复合体I缺陷引起的疾病?
Rejuvenation Res. 2006 Summer;9(2):191-7. doi: 10.1089/rej.2006.9.191.
9
Purification and characterization of a rotenone-insensitive NADH:Q6 oxidoreductase from mitochondria of Saccharomyces cerevisiae.来自酿酒酵母线粒体的鱼藤酮不敏感型NADH:Q6氧化还原酶的纯化与特性分析
Eur J Biochem. 1988 Sep 15;176(2):377-84. doi: 10.1111/j.1432-1033.1988.tb14292.x.
10
Roles of bound quinone in the single subunit NADH-quinone oxidoreductase (Ndi1) from Saccharomyces cerevisiae.结合醌在酿酒酵母单亚基NADH-醌氧化还原酶(Ndi1)中的作用。
J Biol Chem. 2007 Mar 2;282(9):6012-20. doi: 10.1074/jbc.M610646200. Epub 2007 Jan 2.

引用本文的文献

1
The role of gene duplication and paralog specialisation in the evolution of the mammalian PRPS complex.基因复制和旁系同源基因特化在哺乳动物PRPS复合体进化中的作用。
Nat Commun. 2025 Jul 8;16(1):6076. doi: 10.1038/s41467-025-61216-z.
2
Evolutionary origins and innovations sculpting the mammalian PRPS enzyme complex.塑造哺乳动物PRPS酶复合物的进化起源与创新
bioRxiv. 2024 Oct 1:2024.10.01.616059. doi: 10.1101/2024.10.01.616059.
3
Mitochondrial inorganic polyphosphate is required to maintain proteostasis within the organelle.线粒体无机多聚磷酸盐是维持细胞器内蛋白质稳态所必需的。
Front Cell Dev Biol. 2024 Jul 10;12:1423208. doi: 10.3389/fcell.2024.1423208. eCollection 2024.
4
Current advances in gene therapy of mitochondrial diseases.线粒体疾病的基因治疗新进展。
J Transl Med. 2022 Dec 5;20(1):562. doi: 10.1186/s12967-022-03685-0.
5
Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux.用匹鲁卡品进行化学基因组学研究确定C1orf115为药物外排的调节因子。
Nat Chem Biol. 2022 Dec;18(12):1370-1379. doi: 10.1038/s41589-022-01109-0. Epub 2022 Aug 15.
6
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD and SIRT3.神经纤维瘤病缺失细胞的肿瘤生长是由呼吸作用下降驱动的,并受到 NAD 和 SIRT3 的阻碍。
Cell Death Differ. 2022 Oct;29(10):1996-2008. doi: 10.1038/s41418-022-00991-4. Epub 2022 Apr 7.
7
Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.治疗线粒体疾病的方法:“一刀切”与“精准医学”策略
Pharmaceutics. 2020 Nov 11;12(11):1083. doi: 10.3390/pharmaceutics12111083.
8
eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma.真核翻译起始因子 4A 促进胰腺导管腺癌的致癌翻译程序。
Nat Commun. 2019 Nov 13;10(1):5151. doi: 10.1038/s41467-019-13086-5.
9
Arabidopsis thaliana alternative dehydrogenases: a potential therapy for mitochondrial complex I deficiency? Perspectives and pitfalls.拟南芥替代脱氢酶:治疗线粒体复合物 I 缺陷的潜在方法?展望与挑战。
Orphanet J Rare Dis. 2019 Oct 29;14(1):236. doi: 10.1186/s13023-019-1185-3.
10
Differential Effects of Yeast NADH Dehydrogenase (Ndi1) Expression on Mitochondrial Function and Inclusion Formation in a Cell Culture Model of Sporadic Parkinson's Disease.酵母烟酰胺腺嘌呤二核苷酸脱氢酶(Ndi1)表达对散发性帕金森病细胞培养模型中线粒体功能和包涵体形成的差异影响。
Biomolecules. 2019 Mar 27;9(4):119. doi: 10.3390/biom9040119.